Diarrhea 4, Malabsorptive, Congenital
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutant neurogenin-3 in congenital malabsorptive diarrhea.
|
16855267 |
2006 |
Diarrhea 4, Malabsorptive, Congenital
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Mutant neurogenin-3 in congenital malabsorptive diarrhea.
|
16855267 |
2006 |
Diarrhea 4, Malabsorptive, Congenital
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Diarrhea 4, Malabsorptive, Congenital
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Neonatal diabetes mellitus
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
A novel NEUROG3 mutation in neonatal diabetes associated with a neuro-intestinal syndrome.
|
28940958 |
2018 |
Neonatal diabetes mellitus
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
We hypothesized that null mutations in NEUROG3 might be responsible for the disease in a patient with permanent neonatal diabetes and severe congenital malabsorptive diarrhea.
|
21378176 |
2011 |
Neonatal diabetes mellitus
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
This report describes a newly identified nonsense mutation in human NEUROG3 that in the homozygous state is associated with neonatal diabetes and malabsorptive diarrhea.
|
21490072 |
2011 |
Neonatal diabetes mellitus
|
0.330 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Diabetes Mellitus, Non-Insulin-Dependent
|
0.170 |
GeneticVariation
|
disease |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.170 |
GeneticVariation
|
disease |
BEFREE |
By reanalyzing publicly available type 2 diabetes (T2D) genome-wide association studies (GWAS) data for 70,127 subjects, we identify seven novel associated regions, five driven by common variants (LYPLAL1, NEUROG3, CAMKK2, ABO, and GIP genes), one by a low-frequency (EHMT2), and one driven by a rare variant in chromosome Xq23, rs146662057, associated with a twofold increased risk for T2D in males. rs146662057 is located within an active enhancer associated with the expression of Angiotensin II Receptor type 2 gene (AGTR2), a modulator of insulin sensitivity, and exhibits allelic specific activity in muscle cells.
|
29358691 |
2018 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.170 |
GeneticVariation
|
disease |
BEFREE |
We have sequenced NGN3 in KPD patients and screened gene variants in T2DM and controls (n = 232).
|
18093211 |
2008 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.170 |
GeneticVariation
|
disease |
BEFREE |
However, for these SNPs, only modest associations were found with a higher incidence of T2D: hazard ratios of 2.03 [1.00-4.11] for MMP26 (rs2499953 P = 0.05) and 1.33 [1.02-1.73] for NGN3 (rs10823406 P = 0.03).
|
18210030 |
2008 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.170 |
GeneticVariation
|
disease |
BEFREE |
Genetic variation of Neurogenin 3 is slightly associated with hyperproinsulinaemia and progression toward type 2 diabetes.
|
18072012 |
2008 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.170 |
GeneticVariation
|
disease |
BEFREE |
The goal of this study was to establish whether NEUROG3 gene variants are contributing to T2D in an Italian T2D cohort.
|
17146417 |
2006 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.170 |
GeneticVariation
|
disease |
BEFREE |
Polymorphisms of these genes (Ala45Thr [NEUROD1], Ser199Phe [NEUROG3], and Ala98Val [TCF1]) have been postulated to influence the development of type 2 diabetes.
|
15277395 |
2004 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.170 |
GeneticVariation
|
disease |
BEFREE |
Mutations and polymorphisms of ngn3 gene are not significantly associated with Type II (non-insulin-dependent) diabetes mellitus in the Japanese subjects.
|
11270683 |
2001 |
Diarrhea
|
0.140 |
GeneticVariation
|
phenotype |
BEFREE |
Four patients (two males, two females) were diagnosed with homozygous mutations in NEUROG3 on the basis of congenital malabsorptive diarrhea and diabetes.
|
27533310 |
2016 |
Diarrhea
|
0.140 |
GeneticVariation
|
phenotype |
BEFREE |
We hypothesized that null mutations in NEUROG3 might be responsible for the disease in a patient with permanent neonatal diabetes and severe congenital malabsorptive diarrhea.
|
21378176 |
2011 |
Diarrhea
|
0.140 |
GeneticVariation
|
phenotype |
BEFREE |
This report describes a newly identified nonsense mutation in human NEUROG3 that in the homozygous state is associated with neonatal diabetes and malabsorptive diarrhea.
|
21490072 |
2011 |
Diarrhea
|
0.140 |
GeneticVariation
|
phenotype |
BEFREE |
A newly discovered disorder characterized by malabsorptive diarrhea and a lack of intestinal enteroendocrine cells is caused by loss-of-function mutations in NEUROG3.
|
16855267 |
2006 |
Diarrhea
|
0.140 |
Biomarker
|
phenotype |
HPO |
|
|
|
Malabsorption Syndrome
|
0.120 |
AlteredExpression
|
group |
BEFREE |
Biallelic mutations of the gene encoding the transcription factor NEUROG3 are associated with a rare disorder that presents in neonates as generalized malabsorption - due to a complete absence of enteroendocrine cells - followed, in early childhood or beyond, by insulin-dependent diabetes mellitus (IDDM).
|
31805014 |
2020 |
Malabsorption Syndrome
|
0.120 |
Biomarker
|
group |
BEFREE |
The NEUROG3 gene (NEUROG3) is therefore a candidate for the cause of a newly discovered autosomal recessive disorder characterized by generalized malabsorption and a paucity of enteroendocrine cells.
|
16855267 |
2006 |
Malabsorption Syndrome
|
0.120 |
Biomarker
|
group |
HPO |
|
|
|
Diabetes Mellitus, Insulin-Dependent
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
We report two patients with biallelic functionally null variants of the NEUROG3 gene who nonetheless did not present with IDDM during infancy, but instead developed permanent IDDM during middle childhood ages.
|
31805014 |
2020 |